Molecular Formula: C38H76N2O14
Molecular weight: 785.0 g/mol
CAS No: 117772-70-0
ATC Code: J01FA10
Drug Class: macrolide antibiotics
General Properties:
Azithromycin dihydrate is a hydrate. It contains an azithromycin.
Azithromycin is an antibacterial prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of certain bacterial infections, such as:
Various bacterial respiratory diseases, including community-acquired pneumonia, acute sinus and ear infections, acute worsening of chronic bronchitis, and throat and tonsil infections. Pelvic inflammatory disease.
Genital ulcer disease and infections of the urethra and cervix
Infections of the skin
Drug Database, Clinicalinfo.hiv.gov
Azithromycin Dihydrate is the dihydrate form of azithromycin, an orally bioavailable azalide derived from erythromycin, and a member of a subclass of macrolide antibiotics, with anti-bacterial activity. Upon oral administration, azithromycin reversibly binds to the 23S rRNA of the 50S ribosomal subunit of the bacterial ribosome of susceptible microorganisms, thereby inhibiting the translocation step of protein synthesis by preventing the assembly of the 50S ribosomal subunit. This inhibits bacterial protein synthesis, inhibits cell growth and causes cell death.
Indication:
Azithromycin is used to treat certain bacterial infections, such as bronchitis; pneumonia; sexually transmitted diseases (STD); and infections of the ears, lungs, sinuses, skin, throat, and reproductive organs.